All Stories

  1. Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study

    Article • Current Drug Metabolism, December 2020, Bentham Science Publishers

    Dr Abdullatif Taha Babakr, Rashid Mir, Chandan Jha

  2. Heterozygosity in LDLR rs2228671 and rs72658855 Gene is Associated with Increased Risk of Developing Coronary Artery Disease in India –A Case-Control Study

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, March 2020, Bentham Science Publishers

    Chandan Jha, Shaheena Banu

  3. MicroRNA-224 (rs188519172 A>G) Gene Variability is Associated with a Decreased Susceptibility to Coronary Artery Disease: A Case-Control Study

    Article • MicroRNA, April 2019, Bentham Science Publishers

    Rashid Mir, Shaheena Banu, Chandan Jha, Imadeldin Elfaki

  4. Potential impact of microRNA-423 gene variability in coronary artery disease

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, January 2019, Bentham Science Publishers

    Chandan Jha, Rashid Mir, Shaheena Banu